EPILLO Health to Begin the Private Sale of the EPILLO Token from 30th October, 2022

Epillo Health Systems OÜ is a company focused on consumer health and fitness solutions. Through the implementation of blockchain technology, IoT, artificial intelligence and Web 3.0, the Epillo group aims to reduce the healthcare barriers and provide quality care, increase efficiency and access to care, and improve patient satisfaction to redefine the next era of this industry.

On October 30th 2022, the company will launch an exclusive early bird sale of the EPILLO token. This is an opportunity to enter the vast and futuristic Epillo ecosystem and contribute to their future developments.

About the Token

Epillo Health Token (EPILLO) is the native token of Epillo Health Systems. Developed using next generation smart contract standard, ERC-1155, the token will be deployed on the Polygon chain, an ethereum scaling blockchain. By the end of the year, the company expects the EPILLO token to be available on multiple centralized exchanges. Additionally,  the token will also be available for customers of the Fitmint Wear, a next generation wearable device from which users will be able to mint the token as an incentivisation mechanism to become more physically active. The total supply of the token is capped at 5 billion.

Utilities

As previously mentioned, one of the biggest use cases the token will have is to incentivise users of the Fitmint Wear to become more physically active through the gamification of workouts. Through this mechanism, the more calories you burn, the more EPILLO you will generate. However, this is not the only intended use for the token.  The goal of the token is to create a sustainable economy by offering multiple utilities in the entire Epillo Ecosystem (consumer healthcare, health-tech and digital health, health food and beverages, and blockchain health and fitness). EPILLO will  have multiple uses, including but not limited to:

• Purchase and powering of the Web 3.0 smartwatch.
• Availing global health consultation and digital health services.
• Access to gameplay in Fitmint Wear.
• Gene/DNA testing.
• Health and fitness e-commerce marketplace.
• Minting NFTs and access to NFT marketplace.
• Staking and swapping.
• Redemption against health-food offerings.
• Medical fundraising in the research projects.
• Investments in retail health stores.

Pre-sale of the Token

The first pre-sale of the EPILLO token will begin on November 15th, 2022. For this first stage, the company expects to sell 10% of the total supply at a discounted price of $ 0.55 i.e., at a staggering discount of 33% from its premium listing price. Furthermore, for the benefit of the community and the investors, the EPILLO coins 10% of the tokens sold during the private sale be generated at the Token Generation Event and the rest will have a two months vesting period and will be released to the wallets 25 % each month thereafter once this period expires. The company will initiate the listing in exchanges in December 2022  and simultaneously the Token Generation Event will take place.

The allocation of the pre-sale will be distributed as follows:

• 10% – Development of Blockchain-based IoT & smart wearables
• 15 % – Furtherance of Blockchain & Health-Tech Research & development including the development of Tech on WIPO gazetted patent on the blockchain-based drug-food interactions. This includes purchasing of AI and ML Markers.
• 30 % – Liquidity for listing, fee for exchanges
• 20 % – Retail Health & Medical Infrastructure [Global expansion]
• 10 % – Supply of Health & Medical products & services
• 10 % – Marketing
• 5 % – Team Building

Conclusion

The Epillo Health Systems group is a well-established company in the healthcare industry, and is expected to develop even further in the fitness sector with its upcoming wearable solution launch. The pre-sale of the token represents a unique opportunity for interested investors and members of the healthcare and fitness community to take part in this project.

Disclaimer: Coinspeaker is not responsible for the trustworthiness, quality, accuracy of any materials on this page. We recommend you conduct research on your own before taking any decisions related to the products/companies presented in this article. Coinspeaker is not liable for any loss that can be caused due to your use of any services or goods presented in the press release.